Zimmer Biomet Holdings (LTS:0QQD) FFO


LTS:0QQD Zimmer Biomet Holdings Inc LTS:0QQD
72 GF Score
Price CHF77.38
GF Value CHF106.97
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0QQD
72GF Score
Zimmer Biomet Holdings Inc LTS:0QQD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zimmer Biomet Holdings (LTS:0QQD) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF77.38 is trading 27.7% below its estimated GF Value™ of CHF106.97.

Key valuation signals for LTS:0QQD:

  • FFO:
  • GF Value™: CHF106.97 vs. price of CHF77.38 (27.7% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the LTS:0QQD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
72GF Score

Get the complete analysis for LTS:0QQD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF77.38
Price
CHF106.97
GF Value